Sarepta's Setback Deepens With Another Gene Therapy Fatality

Why did Sarepta shares plunge recently? How will Union Pacific–Norfolk Southern merger impact railroads? What caused Nvidia to gain despite US-China tech tensions? Why is Trump criticizing Fed Chair Jerome Powell? How will Trump's proposed EU tariffs affect markets? What led to Netflix stock drop despite earnings beat? Why are AI regulations causing industry pushback?

Sarepta's Setback Deepens With Another Gene Therapy Fatality

benzinga.com/analyst-stock-ratings/analyst-color/25/07/46497110/sareptas-setback-deepens-with-another-gene-therapy-fatality

Sarepta Therapeutics (NASDAQ:SRPT) shares plummeted on Friday following reports of a third patient death linked to its gene therapy pipeline this year, further clouding investor confidence despite the company’s recent efforts to provide clarity on its restructuring and FDA label plans.…

This story appeared on benzinga.com, 2025-07-18 15:43:44.